跳至主要内容
临床试验/CTRI/2022/07/043968
CTRI/2022/07/043968招募中未知

A Prospective, Multicenter, Observational Registry of Metastatic Colorectal cancer (mCRC) Disease to determine Demographics, Clinical features, Molecularfeatures and Treatment outcomes in patients undergoing treatment at participating centers.

Dr Reddys Laboratories0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • ? Metastatic adenocarcinoma of colon or rectum
  • ? Inoperable and eligible for first line systemic therapy
  • ? Age = 18yrs.
  • ? Signed informed consent.

排除标准

  • ? Any participants who received his or her treatment at
  • participating study sites prior to enrolment except for
  • patients with metachronous mCRC
  • ? Non-metastatic Colorectal cancer

研究者

发起方
Dr Reddys Laboratories

相似试验